JP2003510320A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510320A5
JP2003510320A5 JP2001526531A JP2001526531A JP2003510320A5 JP 2003510320 A5 JP2003510320 A5 JP 2003510320A5 JP 2001526531 A JP2001526531 A JP 2001526531A JP 2001526531 A JP2001526531 A JP 2001526531A JP 2003510320 A5 JP2003510320 A5 JP 2003510320A5
Authority
JP
Japan
Prior art keywords
group
alkyl
sulfonyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001526531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510320A (ja
JP5068913B2 (ja
Filing date
Publication date
Priority claimed from EP99810871A external-priority patent/EP1088815A1/en
Application filed filed Critical
Publication of JP2003510320A publication Critical patent/JP2003510320A/ja
Publication of JP2003510320A5 publication Critical patent/JP2003510320A5/ja
Application granted granted Critical
Publication of JP5068913B2 publication Critical patent/JP5068913B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001526531A 1999-09-28 2000-09-28 薬剤活性のあるスルホニルアミノ酸誘導体 Expired - Fee Related JP5068913B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99810871.6 1999-09-28
EP99810871A EP1088815A1 (en) 1999-09-28 1999-09-28 Pharmaceutically active sulfonyl amino acid derivatives
PCT/IB2000/001382 WO2001023379A1 (en) 1999-09-28 2000-09-28 Pharmaceutically active sulfonyl amino acid derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012033338A Division JP2012111777A (ja) 1999-09-28 2012-02-17 薬剤活性のあるスルホニルアミノ酸誘導体

Publications (3)

Publication Number Publication Date
JP2003510320A JP2003510320A (ja) 2003-03-18
JP2003510320A5 true JP2003510320A5 (cg-RX-API-DMAC7.html) 2011-09-01
JP5068913B2 JP5068913B2 (ja) 2012-11-07

Family

ID=8243051

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001526531A Expired - Fee Related JP5068913B2 (ja) 1999-09-28 2000-09-28 薬剤活性のあるスルホニルアミノ酸誘導体
JP2012033338A Withdrawn JP2012111777A (ja) 1999-09-28 2012-02-17 薬剤活性のあるスルホニルアミノ酸誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012033338A Withdrawn JP2012111777A (ja) 1999-09-28 2012-02-17 薬剤活性のあるスルホニルアミノ酸誘導体

Country Status (10)

Country Link
US (1) US7638538B1 (cg-RX-API-DMAC7.html)
EP (2) EP1088815A1 (cg-RX-API-DMAC7.html)
JP (2) JP5068913B2 (cg-RX-API-DMAC7.html)
AT (1) ATE440838T1 (cg-RX-API-DMAC7.html)
AU (1) AU783651B2 (cg-RX-API-DMAC7.html)
CA (1) CA2384997A1 (cg-RX-API-DMAC7.html)
DE (1) DE60042831D1 (cg-RX-API-DMAC7.html)
ES (1) ES2332575T3 (cg-RX-API-DMAC7.html)
IL (1) IL148874A0 (cg-RX-API-DMAC7.html)
WO (1) WO2001023379A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
EP1088815A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonyl amino acid derivatives
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
EA009035B1 (ru) * 2000-12-13 2007-10-26 Уиет Получение гетероциклических сульфонамидных ингибиторов бета-амилоида
KR20040007497A (ko) 2001-04-16 2004-01-24 에자이 가부시키가이샤 신규 1h-인다졸 화합물
AU2002331253B2 (en) * 2001-07-23 2008-04-03 Laboratoires Serono Sa Arylsulfonamide derivatives as C-JUN-N-terminal kinases (JNK'S) inhibitors
JP4414881B2 (ja) 2002-05-31 2010-02-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾール化合物およびこれを含んでなる医薬組成物
IL165265A0 (en) 2002-06-11 2005-12-18 Wyeth Corp Substituted phenylsulfonamide inhibitors of beta amyloid production
WO2004031123A1 (en) * 2002-10-02 2004-04-15 Aventis Pharma Deutschland Gmbh Hydroxyphenylundecane derivatives, a process for their production and their use
CL2004000647A1 (es) 2003-03-31 2005-02-04 Wyeth Corp Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am
US7705052B2 (en) 2003-09-12 2010-04-27 Merck Serono Sa Sulfonamide derivatives for the treatment of diabetes
US7399778B2 (en) 2004-01-16 2008-07-15 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
US20060094753A1 (en) 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
US7803824B2 (en) 2004-10-29 2010-09-28 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US20060223807A1 (en) 2005-03-29 2006-10-05 University Of Massachusetts Medical School, A Massachusetts Corporation Therapeutic methods for type I diabetes
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509157A (cg-RX-API-DMAC7.html) * 1964-07-24 1966-01-25
AU473887B2 (en) * 1975-05-30 1975-07-10 Kyorin Pharmaceutical Co. Ltd. Novel pyrazole derivatives
JPH09104672A (ja) * 1995-08-08 1997-04-22 Ono Pharmaceut Co Ltd ヒドロキサム酸誘導体
PT757984E (pt) * 1995-08-08 2003-02-28 Ono Pharmaceutical Co Derivados de acido hidroxamico uteis para inibir a gelatinase
NZ333825A (en) * 1996-07-22 2000-10-27 Monsanto Co Metalloprotease inhibitors particularly MMP-13
DE69828783T2 (de) * 1997-03-04 2006-01-12 Pharmacia Corp. Hydroxamsäure-sulfonamid-derivate mit amidiertem aromatischen ring
US6043083A (en) * 1997-04-28 2000-03-28 Davis; Roger J. Inhibitors of the JNK signal transduction pathway and methods of use
AU758570B2 (en) * 1997-07-15 2003-03-27 Mediquest Therapeutics, Inc. Novel polyamine analogues as therapeutic and diagnostic agents
US6646149B1 (en) * 1997-07-15 2003-11-11 Nicolaas M. J. Vermeulin Polyamine analogues as therapeutic and diagnostic agents
SK11692000A3 (sk) * 1998-02-04 2001-02-12 Novartis Ag Sulfonylaminoderiváty, ktoré inhibujú metaloproteinázy degradujúce matricu, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje
JPH11236369A (ja) * 1998-02-23 1999-08-31 Kotobuki Seiyaku Kk スルホンアミド誘導体及びその製造法並びにこれを含有する医薬組成物
JPH11246527A (ja) * 1998-03-02 1999-09-14 Shionogi & Co Ltd Mmp−8阻害剤
CA2318004A1 (en) * 1999-09-15 2001-03-15 Oridigm Corporation Novel polyamine analogues as therapeutic and diagnostic agents
EP1088815A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonyl amino acid derivatives
WO2001027108A1 (en) * 1999-10-08 2001-04-19 Bristol-Myers Squibb Pharma Company AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Similar Documents

Publication Publication Date Title
JP2003510320A5 (cg-RX-API-DMAC7.html)
KR970015579A (ko) 테트라졸 화합물
AU2002255077B2 (en) Derivatives of N-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
JP2008510828A5 (cg-RX-API-DMAC7.html)
JP2002531564A5 (cg-RX-API-DMAC7.html)
KR950032120A (ko) 인간 nk₃수용기의 선택적 길항제인 화합물, 및 의약품 및 진단기구로서의 그의 용도
JPH10279578A5 (cg-RX-API-DMAC7.html)
CA2436526A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
KR920006314A (ko) 아릴알킬아민, 이의 제조방법 및 이를 함유하는 약제학적 조성물
JP2005523310A5 (cg-RX-API-DMAC7.html)
JP2006521359A5 (cg-RX-API-DMAC7.html)
PT850221E (pt) Derivados de meta-guanidina ureia tioureia ou acido aminobenzoico azaciclico como antagonistas de integrina
RU2003105900A (ru) Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью
PE20040667A1 (es) Derivados de cinamida
BR1100514A (pt) Processo para a preparação de compostos derivados do ácido benzimidazolino - 2 - oxo - 1 - carboxìlico; produto / composto / composição
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
DE602004031722D1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
RU2004135567A (ru) Основные непептидные антагонисты брадикинина и их фармацевтические композиции
US20040087585A1 (en) Peptide deformylase inhibitors
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
GB2369616A (en) Isoxazolylalkylpiperazine and -piperidine derivatives having selective biological activity at dopamine D3 or D4 receptor
G Zarate et al. Synthetic approaches to heterocyclic guanidines with biological activity: An update
JPWO1994002472A1 (ja) チアゾリン誘導体
JP2005517016A5 (cg-RX-API-DMAC7.html)
US20060058396A1 (en) Amide compounds for the potentiation of cholinergic activity